Abstract: Disclosed are compounds of a formula provided herein that show efficacy in the inhibition of SOX18 protein activity, and in particular with respect to the ability of SOX18 to bind DNA and/or particular protein partners. Further, methods of treating angiogenesis- and/or lymphangiogenesis-related diseases, disorders or conditions, such as cancer metastasis and vascular cancers, are provided herein.

Abstract: The present invention relates to novel processes for recovering iron values from the bauxite residue. It comprises drying the red mud either directly or after neutralizing or after water washing. The bauxite residue was treated with iron nanoparticles of varying the size from 100-1000 nm, heating in muffle furnace or inductive furnace at the temperature 700-800° C. The invention resulted in increasing in magnetic properties of a selected species by coating of the iron particles on their surfaces. The iron oxides Fe2O3 and ?-FeOOH (goethite) present in the bauxite residue was converted to Fe3O4 (magnetite) after the treatment using inductive heating. Hence, magnetic susceptibility of the particles enhances and can be separated by magnetic separator and ultimately separated from the nonmagnetic material. Furthermore, the isolated iron enriched material was used for various applications such as reduction of arsenic, chemical oxygen demand (COD) in wastewater.

Abstract: Disclosed are compounds of a formula provided herein that show efficacy in the inhibition of SOX18 protein activity, and in particular with respect to the ability of SOX18 to bind DNA and/or particular protein partners. Further, methods of treating angiogenesis- and/or lymphangiogenesis-related diseases, disorders or conditions, such as cancer metastasis and vascular cancers, are provided herein.

Abstract: Disclosed are compounds of a formula provided herein that show efficacy in the inhibition of SOX18 protein activity, and in particular with respect to the ability of SOX18 to bind DNA and/or particular protein partners. Further, methods of treating angiogenesis- and/or lymphangiogenesis-related diseases, disorders or conditions, such as cancer metastasis and vascular cancers, are provided herein.

Abstract: Disclosed are compounds of a formula provided herein that show efficacy in the inhibition of SOX18 protein activity, and in particular with respect to the ability of SOX18 to bind DNA and/or particular protein partners. Further, methods of treating angiogenesis- and/or lymphangiogenesis-related diseases, disorders or conditions, such as cancer metastasis and vascular cancers, are provided herein.